Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.69 |
| ▸ | TP53 | P04637 | 2/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | KIF11 | P52732 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28276097 | 0.90 | MEN1 (0.61) | ALDH1A1CYP3A4TDP1TP53HSD17B10 | |
| SCHEMBL49836 | 0.90 | — | — | |
| Methane SCHEMBL747668 | 0.87 | — | — | |
| SCHEMBL8219033 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL28190746 | 0.87 | — | — | |
| SCHEMBL5316147 | 0.87 | — | — | |
| SCHEMBL28315486 | 0.87 | — | — | |
| Benzene SCHEMBL21624953 | 0.84 | MAPT (0.53) | ALDH1A1CYP3A4TDP1TP53HSD17B10 | |
| Benzene SCHEMBL27034677 | 0.84 | MAPT (0.53) | ALDH1A1CYP3A4TDP1TP53HSD17B10 | |
| SCHEMBL967694 | 0.83 | IDO1 (0.50) | ALDH1A1CYP3A4TDP1TP53HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023149761-A1 | ORGANIC MOLECULES USABLE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-10 | — | — | WO | disclosed |
| US-20210036235-A1 | ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-02-04 | — | — | US | disclosed |
| CN-107607516-A | A kind of chemical sensor of Raman enhancing and preparation method thereof | 电子科技大学 | 2018-01-19 | — | — | CN | disclosed |
| US-9212200-B2 | Nanostructure having metal nanoparticles and method of assembly thereof | BAE SYSTEMS INFORMATION AND ELECTRONIC SYSTEMS INTEGRATION INC. (US) | 2015-12-15 | — | — | US | disclosed |
| US-20140135516-A1 | Nanostructure having metal nanoparticles and method of assembly thereof | . | 2014-05-15 | — | — | US | disclosed |
| EP-2330159-B1 | ELECTRET AND ELECTROSTATIC INDUCTION CONVERSION DEVICE | ASAHI GLASS CO LTD (JP) | 2013-04-24 | — | — | EP | disclosed |
| EP-1699403-B1 | GECKO-LIKE FASTENERS FOR DISPOSABLE ARTICLES | KIMBERLY CLARK CO (US) | 2012-08-15 | — | — | EP | disclosed |
| US-8129869-B2 | Electret and electrostatic induction conversion device | ASAHI GLASS COMPANY, LIMITED (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20110166299-A1 | ELECTRET AND ELECTROSTATIC INDUCTION CONVERSION DEVICE | ASAHI GLASS COMPANY, LIMITED | 2011-07-07 | — | — | US | disclosed |
| EP-2330159-A1 | ELECTRET AND ELECTROSTATIC INDUCTION CONVERSION DEVICE | Asahi Glass Company Limited (JP) | 2011-06-08 | — | — | EP | disclosed |
| US-7790724-B2 | c-fms kinase inhibitors | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-09-07 | — | — | US | disclosed |
| US-3940371-A | HYDROLYTIC AND CHEMICAL STABILITY | CASE LESLIE C | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210036235-A1 | ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | TRMT1, TRMT1L, DNTT | ALDH1A1 1237/4885CYP3A4 3106/4885TDP1 1450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.